The Share

The Diamyd Medical share is traded on NASDAQ Stockholm First North (ticker : DMYD B).

About First North

First North is an alternative marketplace operated by an exchange within the NASDAQ OMX group. Companies on First North are not subject to the same rules as companies on the regulated main market. Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on First North may therefore be higher than investing in a company on the main market. All companies with shares traded on First North have a Certified Adviser who monitors that the rules are followed. The Exchange approves the application for admission to trading.

Certified Adviser at First North

FNCA Sweden AB, Humlegårdsgatan 5, Box 5807, SE-102 48 Stockholm. Tel: 08-528 00 399.

Annual Report

  November 3, 2016
  Quarterly Report 1, January 25, 2017

Dear Shareholders and readers

The first quarter of the fiscal year have included activities and new results well in line with the long-term strategy for our drug candidates; the diabetes vaccine Diamyd® and GABA.

Intralymphatic administration of Diamyd® continues to look promising and may prove to be the way forward to strengthen the positive clinical effect that meta analyses of subcutaneous administration have demonstrated. There is a clear rationale for this; studies in...

GABA along with the diabetes vaccine Diamyd® opens up for a complete cure of type 1 diabetes.
Ulf Hannelius, President and CEO

Calendar

 Dates for financial information and other events
Data pager
Data pager
12
February 22, 2017
Börsveckan, Capital market day 2017
Diamyd Medical’s CEO presents the company.
March 20, 2017
Bio Europe Spring
April 5, 2017
Quarterly Report II
Quarterly Report 2 2016/2017
June 28, 2017
Quarterly Report III
Quarterly Report 3 2016/2017
 

We are dedicated to finding a cure for autoimmune diabetes through pharmaceutical development and investments in medical and stem cell technologies

 

Ten largest shareholders as of December 30, 2016

ShareholderA SharesB SharesCapital %Votes %
Essen-Möller, Anders 1 278 112 3 666 521 16.8 40.1
Avanza Pension 4 026 947 13.7 9.8
Lindkvist, Bertil 3 815 040 12.9 9.3
Nordnet Pensionsförsäkring AB 876 966 3.0 2.1
Swedbank Försäkring 523 089 1.8 1.3
Försäkrings AB Skandia 272 826 0.9 0.7
Relbo AB 237 776 0.8 0.6
Handelsbanken Liv 232 380 0.8 0.6
Bohlin, Lennart 224 568 0.8 0.5
Waldolf, Ann Christin 198 666 0.7 0.5
Remaining shareholders 14 139 671 47.8 34.5
Total 1 278 112 28 214 450 100.0 100.0